Protein-bound Toxins
Protein-bound Toxins - Related Videos
08:19
Toxin Induction and Protein Extraction from Fusarium spp. Cultures for Proteomic Studies
0 Views •
Cited by 10 •
2010
Protein extraction for proteomic analyses in fungal species requires high levels of standardization to be accomplished according with the minimum information about a proteomic experiment (MIAPE) guidelines. We present a video-protocol that includes a procedure for minimizing experimental bias during toxin induction and protein extraction from Fusarium spp.
10:41
Detection of Toxin Translocation into the Host Cytosol by Surface Plasmon Resonance
0 Views •
Cited by 14 •
2012
In this report, we describe how surface plasmon resonance is used to detect toxin entry into the host cytosol. This highly sensitive method can provide quantitative data on the amount of cytosolic toxin, and it can be applied to a range of toxins.
09:14
Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique
0 Views •
Cited by 4 •
2016
In this protocol, we describe a novel BrdU-ChIP-Slot-Western technique to examine proteins and histone modifications associated with newly synthesized or nascent DNA.
05:07
An Enhanced Crosslinking Immunoprecipitation Method for Efficient Identification of Protein-bound RNA in Mouse Testes
0 Views •
2025
This video demonstrates the enhanced crosslinking immunoprecipitation (eCLIP) method for identifying RNA-binding proteins in mouse testis. eCLIP enables the precise identification of binding sites where RNA-binding proteins (RBPs) interact with their target RNAs.
03:28
A Permeable Membrane Insert-Based Infection System to Study the Impact of Bacterial Toxins
0 Views •
2025
This video demonstrates a permeable membrane insert-based infection system to assess the impact of secreted bacterial toxins. By eliminating direct contact between the bacterial pathogen and the host cells using a permeable membrane, this technique allows for studying the effect of toxins secreted by pathogenic bacteria on mammalian host cells.
FAQs
Changes in binding affinity or protein concentration can shift the balance between bound and unbound toxin. A stronger association or greater protein availability may retain more toxin in a bound reservoir, whereas reduced binding can increase the fraction available to cross membranes and reach cellular targets. These shifts can change toxicity, persistence, metabolism, and elimination, even when total toxin levels appear similar.
The unbound fraction remains available to cross biological membranes and interact with cellular targets. Because these steps directly connect circulating toxin with tissue effects, changes in unbound concentration can alter biological activity without requiring a proportional change in total toxin. Assessing this fraction therefore helps explain why similar measured toxin burdens may produce different toxic responses.
Reversible binding can function as a temporary reservoir that releases toxin as the unbound fraction is used, metabolized, or eliminated. This relationship may influence how long biologically relevant exposure persists. In toxicology, considering both the reservoir and the available fraction helps connect binding behavior with the timing of effects and with observed differences in clearance.
Toxicology results should be interpreted in relation to both the amount associated with proteins and the fraction that remains biologically available. Binding information can clarify whether a measured toxin level may overstate or understate immediate cellular exposure. This context supports more accurate evaluation of distribution, persistence, metabolism, elimination, and potential toxicity.
Drug–toxin interactions matter because they may change the relationship between protein-associated material and the biologically available fraction. Evaluating these interactions helps determine whether exposure, distribution, or clearance could differ from expectations based on the toxin alone. This assessment is relevant when interpreting toxicology findings and when estimating the potential effects of combined exposures.
Protein-binding information can help evaluate therapies intended to reduce exposure to the active toxin fraction. It also supports biomarker development by identifying measurements that better reflect biologically relevant exposure rather than total amount alone. Incorporating binding, distribution, and clearance characteristics can improve individualized risk assessment and help explain variation in toxic effects among patients.